as on September 17, 2025 at 9:37 pm IST
Day's Low
Day's High
1.87%
Downside
2.80%
Upside
52 Week's Low
52 Week's High
62.24%
Downside
111.21%
Upside
Check Alx Oncology Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$57.8M
EPS (TTM)
-1.1146
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-117.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
906467200.00%
Compare market cap, revenue, PE, and other key metrics of Alx Oncology Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $57.8M | -97.17% | NA | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Alx Oncology Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alx Oncology Holdings Inc investment value today
Current value as on today
₹53,681
Returns
Returns from Alx Oncology Holdings Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Alx Oncology Holdings Inc. Average target price of $2.25
Get share price movements and forecasts by analysts on Alx Oncology Holdings Inc.
What analysts predicted
52.44%UPSIDE
Target Price
$2.25
Current Price
$1.07
Analyzed by
13 Analysts
Target
$2.25
Alx Oncology Holdings Inc target price $2.25, a slight upside of 52.44% compared to current price of $1.07. According to 13 analysts rating.
Investment in Alx Oncology Holdings Inc Shares on INDmoney has grown by 685.71% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:685.71% versus previous 30 day period
Search interest for Alx Oncology Holdings Inc Stock has increased by 163% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:163% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 207.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 118.6%
Price Dip
In the last 7 days, ALXO stock has moved down by -7.7%
Organisation | Alx Oncology Holdings Inc |
Headquarters | 323 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Industry | Commercial Services |
CEO | Mr. Jason W. Lettmann |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Shelly Pinto CPA | Senior VP of Finance & Chief Accounting Officer |
Ms. Venita De Almeida Ph.D. | VP & Head of Research Program Development |
Dr. Allison Dillon Ph.D. | Chief Operating Officer |
Dr. Athanasios Tsiatis M.D. | Senior Vice President of Clinical Development |
Dr. Lin Yeong-Liang M.D., M.S. | Senior Vice President of Drug Safety & Pharmacovigilance |
Ms. Lisa Sauer | Senior Vice President of Regulatory Affairs & Quality Assurance |
Ms. Sue Naim | Senior Vice President of Clinical Operations |
Dr. Barbara J. Klencke M.D. | Interim Chief Medical Officer |
Mr. Jason W. Lettmann | CEO & Director |
Mr. Harish Shantharam C.F.A. | Chief Financial Officer |
Alx Oncology Holdings Inc share price today is $1.07 as on . Alx Oncology Holdings Inc share today touched a day high of $1.1 and a low of $1.05.
Alx Oncology Holdings Inc share touched a 52 week high of $2.26 on and a 52 week low of $0.4 on . Alx Oncology Holdings Inc stock price today i.e. is trending at $1.07,which is 52.65% down from its 52 week high and 164.85% up from its 52 week low.
Alx Oncology Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Alx Oncology Holdings Inc (ALXO) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Alx Oncology Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alx Oncology Holdings Inc share’s latest price of $1.07 as on September 17, 2025 at 9:37 pm IST, you will get 9.3458 shares of Alx Oncology Holdings Inc. Learn more about
fractional shares .
Alx Oncology Holdings Inc stock has given -97.17% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?